Ledger.Open graph →
SEC Form D · Amendment · filed January 27, 2010

BIORELIX INC

Offering
$7.5M
Sold
$5.5M
Exemption
—
Industry
Pharmaceuticals
Location
NEW HAVEN, CT
Type
—

People & firms on this filing (13)

Dov Goldstein · New Haven, CTDirectorWilliam R. Wiesler · New Haven, CTDirectorBrian R. Dixon, Ph.D · New Haven, CTExec · DirectorA. D. Strosberg · New Haven, CTDirectorRonald R. Lennox · New Haven, CTExec · DirectorCampbell D. Murray · New Haven, CTDirectorJeff Fagnan · Waltham, MAExec · DirectorJames Pitkow · San Francisco, CAExec · DirectorRobert Lord · San Francisco, CADirectorMika Salmi · San Francisco, CADirectorHarris B. Kupperman · Miami Beach, FLDirectorE. B. Griswold · Stamford, CTDirectorPhilipe Chambon · New Haven, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗